A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 3, 2015

Primary Completion Date

October 28, 2016

Study Completion Date

July 7, 2017

Conditions

Chronic Hepatitis C Infection

Interventions

DRUG

ombitasvir/paritaprevir/ritonavir and dasabuvir

tablet, ombitasvir coformulated with paritaprevir and ritonavir; tablet, dasabuvir

DRUG

Sofosbuvir

tablet

DRUG

Ribavirin

tablet